Chugai Pharma Manufacturing Co. Ltd (manufacturing of unpackaged products, primary packaging)

Ukraine

All drugs from this manufacturer

  • ACTEMRA

    The drug is used for the treatment of rheumatoid arthritis (in adults), systemic juvenile idiopathic arthritis and polyarticular juvenile idiopathic arthritis (in children from 2 years of age), as well as for the treatment of severe COVID-19 in adults receiving corticosteroids who require oxygen support.

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    tocilizumab 20 mg/ml

    ATC: L04AC07